Press coverage about Intuitive Surgical (NASDAQ:ISRG) has been trending somewhat positive on Monday, Accern Sentiment reports. Accern scores the sentiment of news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Intuitive Surgical earned a daily sentiment score of 0.08 on Accern’s scale. Accern also assigned news headlines about the medical equipment provider an impact score of 45.8486315987978 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Here are some of the headlines that may have impacted Accern Sentiment Analysis’s analysis:

Intuitive Surgical (NASDAQ ISRG) traded up $12.85 on Monday, hitting $391.86. The stock had a trading volume of 967,302 shares, compared to its average volume of 841,400. Intuitive Surgical has a 52 week low of $211.73 and a 52 week high of $405.05. The stock has a market cap of $43,910.00, a P/E ratio of 50.63, a PEG ratio of 5.33 and a beta of 0.47.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 19th. The medical equipment provider reported $2.77 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.99 by $0.78. The company had revenue of $806.10 million during the quarter, compared to the consensus estimate of $753.25 million. Intuitive Surgical had a return on equity of 18.20% and a net margin of 30.16%. The business’s quarterly revenue was up 18.0% on a year-over-year basis. During the same period last year, the business earned $2.06 EPS. sell-side analysts predict that Intuitive Surgical will post 7.85 earnings per share for the current year.

Several equities research analysts recently issued reports on the company. Zacks Investment Research raised Intuitive Surgical from a “hold” rating to a “buy” rating and set a $409.00 price objective for the company in a research note on Wednesday, January 3rd. Cantor Fitzgerald reissued an “overweight” rating on shares of Intuitive Surgical in a research note on Friday. ValuEngine downgraded Intuitive Surgical from a “hold” rating to a “sell” rating in a research note on Friday, December 29th. Evercore ISI assumed coverage on Intuitive Surgical in a research note on Wednesday, January 3rd. They set an “in-line” rating and a $380.00 price target for the company. Finally, Canaccord Genuity reaffirmed a “hold” rating on shares of Intuitive Surgical in a research note on Tuesday, October 17th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $340.63.

In other news, CFO Marshall Mohr sold 6,000 shares of the stock in a transaction dated Monday, October 30th. The stock was sold at an average price of $372.22, for a total transaction of $2,233,320.00. Following the transaction, the chief financial officer now owns 12,316 shares of the company’s stock, valued at approximately $4,584,261.52. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP Jamie Samath sold 959 shares of the stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $398.46, for a total value of $382,123.14. Following the transaction, the vice president now directly owns 536 shares in the company, valued at approximately $213,574.56. The disclosure for this sale can be found here. In the last three months, insiders have sold 55,944 shares of company stock worth $21,432,971. 2.20% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION WARNING: This news story was originally published by Watch List News and is owned by of Watch List News. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with Analyst Ratings Network's FREE daily email newsletter.